DocGo (NASDAQ:DCGO – Get Free Report)‘s stock had its “buy” rating reissued by analysts at Needham & Company LLC in a research report issued on Wednesday, Benzinga reports.
Other analysts have also issued reports about the company. Canaccord Genuity Group restated a “hold” rating and issued a $1.00 price target on shares of DocGo in a report on Tuesday, August 18th. Weiss Ratings reissued a “sell (e+)” rating on shares of DocGo in a research report on Monday, September 14th. Three research analysts have rated the stock with a Buy rating, two have assigned a Hold rating and one has assigned a Sell rating to the company’s stock. Based on data from MarketBeat.com, DocGo has an average rating of “Hold” and a consensus price target of $2.38.
Read Our Latest Report on DocGo
DocGo Price Performance
DocGo (NASDAQ:DCGO – Get Free Report) last issued its quarterly earnings data on Monday, August 17th. The company reported ($0.16) EPS for the quarter, missing analysts’ consensus estimates of ($0.10) by ($0.06). The company had revenue of $73.42 million for the quarter, compared to analyst estimates of $75.35 million. DocGo had a negative return on equity of 40.42% and a negative net margin of 65.29%. Equities analysts predict that DocGo will post -0.22 EPS for the current year.
Institutional Inflows and Outflows
Hedge funds have recently bought and sold shares of the stock. Diversify Advisory Services LLC acquired a new position in shares of DocGo during the 2nd quarter worth approximately $53,000. Empowered Funds LLC acquired a new stake in shares of DocGo in the 2nd quarter valued at approximately $79,000. Ieq Capital LLC bought a new position in shares of DocGo in the second quarter valued at $126,000. Marquette Asset Management LLC acquired a new position in DocGo during the second quarter worth $175,000. Finally, GSA Capital Partners LLP acquired a new position in DocGo during the second quarter worth $517,000. 56.44% of the stock is currently owned by institutional investors.
About DocGo
DocGo Inc (NASDAQ: DCGO) is a healthcare services and technology company that delivers medical care and transportation outside traditional clinical settings. Its platform combines mobile clinical services, technology-enabled care coordination and non-emergency medical transportation to help healthcare providers, government agencies, insurers and employers serve patients in their homes and communities.
The company’s services include ambulance and non-emergency medical transportation, mobile primary and urgent care, remote patient monitoring, diagnostic testing, vaccination programs and community-based healthcare.
Recommended Stories
- Five stocks we like better than DocGo
- Deutsche Bank Makes a Contrarian Call on Netflix—What Does It Mean for Investors?
- O’Reilly Automotive’s Stock Slump Hides a Stronger Business
- McDonald’s Stock Slump Makes Its AI Pricing Bet Even Riskier
- Broadcom’s AI Growth Story Faces a $161 Billion Anthropic Test
Receive News & Ratings for DocGo Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for DocGo and related companies with MarketBeat.com's FREE daily email newsletter.
